{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:05:02Z","timestamp":1778004302159,"version":"3.51.4"},"reference-count":22,"publisher":"Societas Neurologica Japonica","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5692\/clinicalneurol.54.882","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T18:38:00Z","timestamp":1416595080000},"page":"882-887","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of midazolam for L-arginine-resistant headaches during stroke-like episodes in MELAS: a case report"],"prefix":"10.5692","volume":"54","author":[{"given":"Koyo","family":"Tsujikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Hoshiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Yanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488.","DOI":"10.1002\/ana.410160409"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550.","DOI":"10.1212\/WNL.42.3.545"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Yatsuga S, Povalko N, Nishioka J, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 2012;1820:619-624.","DOI":"10.1016\/j.bbagen.2011.03.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ohama E, Ohara S, Ikuta F, et al. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226-233.","DOI":"10.1007\/BF00688185"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sakuta R, Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989;25:594-601.","DOI":"10.1002\/ana.410250611"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mukoyama M, Kazui H, Sunohara N, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of a unique case. J Neurol 1986;233:228-232.","DOI":"10.1007\/BF00314025"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sano M, Ishii K, Momose Y, et al. Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Acta Neurol Scand 1995;92:497-502.","DOI":"10.1111\/j.1600-0404.1995.tb00487.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iizuka T, Sakai F. Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res 2005;2:29-45.","DOI":"10.2174\/1567202052773544"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002;59:816-824.","DOI":"10.1212\/WNL.59.6.816"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Iizuka T, Sakai F. Pathophysiology of stroke-like episodes in MELAS: neuron-astrocyte uncoupling in neuronal hyperexcitability. Future Neurology 2010;5:61-83.","DOI":"10.2217\/fnl.09.71"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Koga Y, Ishibashi M, Ueki I, et al. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology 2002;58:827-828.","DOI":"10.1212\/WNL.58.5.827"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005;64:710-712.","DOI":"10.1212\/01.WNL.0000151976.60624.01"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hirata K, Akita Y, Povalko N, et al. Effect of L-arginine on synaptosomal mitochondrial function. Brain Dev 2007;30:238-245.","DOI":"10.1016\/j.braindev.2007.08.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yoneda M, Ikawa M, Arakawa K, et al. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients. Biochim Biophys Acta 2012;1820:615-618.","DOI":"10.1016\/j.bbagen.2011.04.018"},{"key":"15"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998;35:37-47.","DOI":"10.2165\/00003088-199835010-00003"},{"key":"17"},{"key":"18"},{"key":"19"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009;8:679-690","DOI":"10.1016\/S1474-4422(09)70090-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Iizuka T, Sakai F, Endo M, et al. Response to sumatriptan in headache of MELAS syndrome. Neurology 2003;61:577-578.","DOI":"10.1212\/01.WNL.0000078931.87815.B3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Storer RJ, Akerman S, Shields KG, et al. GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res 2004;1013:188-193.","DOI":"10.1016\/j.brainres.2004.03.068"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u8133\u5352\u4e2d\u69d8\u767a\u4f5c\u6025\u6027\u671f\u306e\u982d\u75db\u767a\u4f5c\u306b\u5bfe\u3057\u3066L-\u30a2\u30eb\u30ae\u30cb\u30f3\u304c\u7121\u52b9\u3067\u30df\u30c0\u30be\u30e9\u30e0\u304c\u6709\u52b9\u3067\u3042\u3063\u305fMELAS\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T20:46:48Z","timestamp":1498164408000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/54.882?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.54.882","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}